Overview

Phase III Study of Two Different Schedules (Weekly and Tri-weekly) of Combination of Gemcitabine and Two Taxanes in MBC

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Multi-center, randomized Phase III study. 4 arms. 360 Patient to enroll. Purpose is evaluate time to progression disease (PD).
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Albumin-Bound Paclitaxel
Docetaxel
Gemcitabine
Paclitaxel